Search results
Results From The WOW.Com Content Network
The Hwang affair, [1] or Hwang scandal, [2] or Hwanggate, [3] is a case of scientific misconduct and ethical issues surrounding a South Korean biologist, Hwang Woo-suk, who claimed to have created the first human embryonic stem cells by cloning in 2004.
The Republicans largely oppose embryonic stem cell research in favor of adult stem cell research which has already produced cures and treatments for cancer and paralysis for example, but there are some high-profile exceptions who offer qualified support for some embryonic stem cell research. [5]
Missouri Constitutional Amendment 2 (The Missouri Stem Cell Research and Cures Initiative) was a state constitutional amendment initiative that concerned stem cell research and human cloning. It allows any stem cell research and therapy in the U.S. state of Missouri that is legal under federal law, including somatic cell nuclear transfer to ...
The promise of stem cells, along with the controversy surrounding it, has made the industry a hot-button issue for many. Despite that promise, we have yet to see huge applicable benefits to humans.
The Southern Baptist Convention opposes human embryonic stem cell research on the grounds that the "Bible teaches that human beings are made in the image and likeness of God (Gen. 1:27; 9:6) and protectable human life begins at fertilization." [71] However, it supports adult stem cell research as it does "not require the destruction of embryos ...
Hwang first caught media attention in South Korea when he announced he had successfully created a cloned dairy cow, Yeongrong-i in February 1999. His alleged success was touted as the fifth instance in the world in cow cloning, with a notable caveat: Hwang failed to provide scientifically verifiable data for the research, giving only media sessions and photo ops.
Sweden forbids reproductive cloning, but allows therapeutic cloning and authorized a stem cell bank. [1] [7] According to modern stem cell researchers, Spain is one of the leaders in stem cell research and currently has one of the most progressive legislations worldwide with respect to human embryonic stem cell (hESC) research. [8]
Although the results were acclaimed as the first "success of gene editing and cell function" [164] in cancer research and "an important milestone in the development and clinical application of gene-edited effector cell therapy," [168] it was far from curing the diseases. One died after the clinical trial, and the other two had recurrent cancer.